lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Exosomal SPINT1-AS1 Promotes the Development of Colorectal Cancer and Serves as a Non-Invasive Biomarker

27 Pages Posted: 26 Apr 2019

See all articles by Chen Li

Chen Li

Shandong University - Department of Clinical Laboratory

Xin Zhang

Shandong University

Chengxi Sun

Shandong University

Yanlei Wang

Shandong University

Rui Zhao

Shandong University - Department of Clinical Laboratory; Shandong University - Shandong Province Key Laboratories of Medicine and Health

Yanli Zhang

Shandong University

Yi Zhang

Shandong University - Department of Clinical Laboratory; Shandong Provincial Medicine and Health - Key Laboratory of Tumor Marker Translational Medicine; Shandong University - Shandong Province Key Laboratories of Medicine and Health

Yongmei Yang

Shandong University

Ailin Qu

Shandong University

Xuewei Zhuang

Shandong University

Chuanxin Wang

Shandong University - Department of Clinical Laboratory

More...

Abstract

Background: The contribution of natural antisense transcripts (NATs) to tumorigenesis is an area of intensive investigation. Previously, we demonstrated highly expressed SPINT1-AS1 in colorectal cancer (CRC) was linked to poor clinical outcome. In this study, we investigated the regulatory role of SPINT1-AS1 on CRC cell phenotypes and determined the expression pattern of exosomal SPINT1-AS1.

Methods: Loss- and gain-of-function assays were used to evaluate the regulation ability of SPINT1-AS1 on CRC cell phenotypes. Strand-specific RT-qPCR was used to detected exosomal SPINT1-AS1 expression in a cohort of serum samples including 100 normal colonoscopy (NC), 93 hyperplastic polyp (HP), 104 inflammatory bowel disease (IBD), 113 adenoma (Ad) and 240 CRC.

Findings: SPINT1-AS1 overexpression significantly promoted CRC cell proliferation and autophagy while inhibited apoptosis in vitro. SPINT1-AS1 overexpression also drove tumorigenesis in vivo. Consistently, SPINT1-AS1 knockdown abolished CRC tumorigenesis manifested as inhibited cell proliferation and autophagy, as well as promoted apoptosis. Interestingly, SPINT1 mRNA overexpression led to the same phenotypes as SPINT1-AS1 knockdown in CRC cells. In addition, exosome-mediated SPINT1-AS1 transfer promoted CRC cells malignant behaviors. High expression of exosomal SPINT1-AS1 was observed in CRC which could distinguish between CRC from NC and benign colorectal diseases. Patients with high expression of exosomal SPINT1-AS1 had adverse clinical manifestation and shorter Disease-free survival (DFS).

Interpretation: SPINT1-AS1 plays a carcinogenic role in CRC via regulating SPINT1 mRNA expression. SPINT1-AS1 can be secreted into exosomes, which suggests that SPINT1-AS1 has potential to act as a non-invasive diagnostic and prognostic biomarker for CRC.

Funding: This work was supported by grant from the Natural Science Foundation of China (81472025, 81772271, 81301506 and 81601846), Shandong Technological Development Project (2018YFJH0505), Shandong Medical and Health Technology Development Project (2018WSB20002), Jinan Science and Technology Development Plan (201805003), Natural Science Foundation of Shandong Province (ZR2015CM030) and Taishan Scholar Program of Shandong Province.

Declaration of Interest: The authors declare no conflict of interest.

Ethical Approval: This study was approved by the Ethics Committee of Qilu Hospital of Shandong University, and written informed consent was signed by each patients.

Keywords: colorectal cancer; natural antisense transcripts; SPINT1-AS1; exosome

Suggested Citation

Li, Chen and Zhang, Xin and Sun, Chengxi and Wang, Yanlei and Zhao, Rui and Zhang, Yanli and Zhang, Yi and Yang, Yongmei and Qu, Ailin and Zhuang, Xuewei and Wang, Chuanxin, Exosomal SPINT1-AS1 Promotes the Development of Colorectal Cancer and Serves as a Non-Invasive Biomarker (April 24, 2019). Available at SSRN: https://ssrn.com/abstract=3377508 or http://dx.doi.org/10.2139/ssrn.3377508

Chen Li

Shandong University - Department of Clinical Laboratory

Jinan, Shandong Province 250033
China

Xin Zhang

Shandong University

27 Shanda Nanlu
South Rd.
Jinan, SD Shandong 250100
China

Chengxi Sun

Shandong University

27 Shanda Nanlu
South Rd.
Jinan, SD Shandong 250100
China

Yanlei Wang

Shandong University

27 Shanda Nanlu
South Rd.
Jinan, SD Shandong 250100
China

Rui Zhao

Shandong University - Department of Clinical Laboratory

Jinan, Shandong
China

Shandong University - Shandong Province Key Laboratories of Medicine and Health

Jinan, Shandong
China

Yanli Zhang

Shandong University

27 Shanda Nanlu
South Rd.
Jinan, SD Shandong 250100
China

Yi Zhang

Shandong University - Department of Clinical Laboratory ( email )

Jinan, Shandong
China

Shandong Provincial Medicine and Health - Key Laboratory of Tumor Marker Translational Medicine ( email )

Jinan
China

Shandong University - Shandong Province Key Laboratories of Medicine and Health ( email )

Jinan, Shandong
China

Yongmei Yang

Shandong University

27 Shanda Nanlu
South Rd.
Jinan, SD Shandong 250100
China

Ailin Qu

Shandong University

27 Shanda Nanlu
South Rd.
Jinan, SD Shandong 250100
China

Xuewei Zhuang

Shandong University

27 Shanda Nanlu
South Rd.
Jinan, SD Shandong 250100
China

Chuanxin Wang (Contact Author)

Shandong University - Department of Clinical Laboratory ( email )

Jinan, Shandong Province 250033
China

Click here to go to TheLancet.com

Paper statistics

Downloads
69
Abstract Views
504
PlumX Metrics